# Justice Barrett Targets "Zombie" Federal Agencies in Supreme Court Oral Arguments

Justice Amy Coney Barrett challenged government lawyers on the scope of executive power during oral arguments this week, focusing her questioning on what legal scholars call "zombie agencies" - federal regulatory bodies that operate without confirmed leadership or proper statutory authority.

The term "zombie agency" describes a federal bureau staffed by officials who lack Senate confirmation or operate beyond the boundaries of their enabling statutes. These agencies continue issuing rules, setting policy, and enforcing regulations despite what critics argue is questionable legal standing.

Barrett's line of questioning signals potential alignment with the Court's originalist wing on administrative law. She probed whether agencies filling vacant leadership positions with acting officials have legitimate authority to make binding decisions affecting private parties. The exchange occurred during arguments in a case examining the breadth of executive power to keep agencies operational during leadership vacancies.

"How do we know these agencies are operating within their statutory mandates?" Barrett asked. Her questions pressed the government's counsel on the distinction between temporary operational continuity and permanent rulemaking authority.

This reflects a broader conservative movement within the Supreme Court to curtail the Chevron doctrine and administrative deference. The Court has already signaled skepticism toward expansive agency power in recent decisions, most notably in West Virginia v. EPA (2022), where the Court limited the Environmental Protection Agency's regulatory reach under the Clean Air Act.

Acting officials typically serve under the Vacancies Reform Act, which permits temporary leadership when Senate-confirmed positions remain empty. However, Barrett's questions suggest some justices question whether these temporary officials retain full rulemaking authority or whether their actions should face heightened scrutiny.

The practical implications are substantial. Federal agencies like the National Labor Relations Board, the Securities and Exchange Commission, and the Food and Drug Administration have all operated with acting officials. Rules issued during these periods could face legal challenges if courts adopt stricter standards for zombie agency authority.

Industry groups monitoring the case view Barrett's intervention as positive. Business organizations have filed amicus briefs arguing that zombie agencies lack democratic legitimacy and create uncertainty for regulated entities unable to predict which rules will survive judicial review.

Government representatives counter that temporary leadership transitions are inevitable and necessary for operational continuity. They warn that invalidating rules issued by acting officials would create regulatory chaos and prevent agencies from protecting public health and safety during leadership gaps.

The case reflects tensions between executive efficiency and administrative law principles requiring clear statutory delegation of authority. If the Court sides with Barrett's apparent skepticism, agencies will need to restrict rulemaking during leadership vacancies or seek congressional action to fill positions more quickly.

The decision could reshape how federal agencies operate and potentially invalidate years of regulations issued by acting officials. Lower courts have already begun questioning zombie agency authority in separate disputes, suggesting this issue will dominate administrative law for years.